Journals / Journal of Experimental and Clinical Medicine / 2019 / Cilt: 36 - Sayı: 3

The effect of intravenous N-acetyl cysteine on the incidence of postoperative atrial fibrillation in coronary artery bypass graft surgery patients

Pages
81–85
Publication Date
2020-02-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that admin-istration IV NAC is an effective way to prevent the POAF after CABG surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atrial fibrillation is the most frequent arrhythmia after open heart surgery.
📊
Key Findings & Data:A total of 60 patients who had undergone isolated CABG surgery be-tween June 2014 – July 2015 in our clinic included in this retrospective study.
💡
Conclusion & Impact:We think that admin-istration IV NAC is an effective way to prevent the POAF after CABG surgery.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Postoperative atrial fibrillation · coronary artery bypass surgery · n-acetyl cysteine

Abstract

Atrial fibrillation is the most frequent arrhythmia after open heart surgery. The aim of this study was to determine the effect of intravenous (IV) N-acetyl cys-teine (NAC) administration in the early postoperative period of coronary ar-tery bypass (CABG) surgery on the incidence of postoperative atrial fibrillation (POAF). A total of 60 patients who had undergone isolated CABG surgery be-tween June 2014 – July 2015 in our clinic included in this retrospective study. The patients divided into two groups: Group 1 (n=30) included the patients who had been administered standard saline solution infusion and Group 2 (n=30) included the patients who had been administered IV NAC (10mg/kg) infusion while they were under mechanical ventilation support. All patients were ad-ministrated oral 600 mg NAC once a day for 5 days after weaning from me-chanical ventilation support. The ECG’s were evaluated for POAF by the same cardiovascular surgeon who was blinded for patient groups. POAF was seen in 12 (40%) patients in Group 1 and 4 (13%) patients in Group 2. The POAF incidence was significantly higher in Group 1 (p=0.020). We think that admin-istration IV NAC is an effective way to prevent the POAF after CABG surgery.

🔖

Cite This Article

SUNGUR, E. C., ALTINAY, L., BUYUKATES, M. (2020). The effect of intravenous N-acetyl cysteine on the incidence of postoperative atrial fibrillation in coronary artery bypass graft surgery patients. Journal of Experimental and Clinical Medicine, Cilt: 36 - Sayı: 3, 81–85. https://ajindex.com/articles/678197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Soleimani A, Hasanzadeh Kiabi F, Emami Zeydi A, et al. Can white blood cell count be used as a predictor of atrial fibrillation following cardiac surgery? A short literature review. Anadolu Kardiyol Derg. 2014; 14(2): 216–217
  2. Gholipour Baradari A, Emami Zeydi A, Ghafari R, et al. A dou¬ble-blind randomized clinical trial comparing different doses of magnesium in cardioplegic solution for prevention of atrial fibril¬lation after coronary artery bypass graft surgery. Cardiovasc Ther. 2016; 34(4): 276–282
  3. Kazemi B, Akbarzadeh F, Safaei N, et al.: Prophylactic high-dose Oral-N-Acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebocontrolled randomized clinical trial. Pacing Clin Electrophysiol 2013, 36:1211–1219
  4. Arfsten D, Johnson E, Thitoff A, et al. Impact of 30-day oral dosing with N-acetyl-Lcysteine on Sprague-Dawley rat physiology. Int J Toxicol 2004;23:239—47
  5. Goettea A, Lendeckel U. Nonchannel drug targets in atrial fibrillation. Pharmacol Ther 2004, 102:17-36
  6. Eslami M, Badkoubeh RS, Mousavi M, et al. Oral ascorbic acid in combination with betablockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery baypas grafting. Tex Heart Inst J 2007;34:268—74
  7. Lertsburapa K, White CM, Kluger J, et al. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 2008;135:405—11
  8. Liu XH, Xu CY, Fan GH. Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery:a meta-analysis of published randomized controlled trials. BMS Cardiovascular Disorders 2014:14(52)
  9. Baker W.L, Anglade M.W, Baker E.L. et al. Use of N-acetylcysteine to reduce postcardiothoracic surgery complications: a meta-analysis. Eur J Cardio-Thoracic Surgery 35(2009): 521-527
  10. Gu WJ, Wu ZJ, Wang PF. et al. N-acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovascular Disorders 2012:12(10)
  11. Ali-Hassan-Sayegh S, Mirhosseini S.J., Rezaeisadrabadia M, et al. Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials. Interactive CardioVascular and Thoracic Surgery 18 (2014) 646–654
  12. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk for